1. Home
  2. KOPN vs ASMB Comparison

KOPN vs ASMB Comparison

Compare KOPN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOPN
  • ASMB
  • Stock Information
  • Founded
  • KOPN 1984
  • ASMB 2005
  • Country
  • KOPN United States
  • ASMB United States
  • Employees
  • KOPN N/A
  • ASMB N/A
  • Industry
  • KOPN Semiconductors
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOPN Technology
  • ASMB Health Care
  • Exchange
  • KOPN Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • KOPN 282.1M
  • ASMB 84.5M
  • IPO Year
  • KOPN 1992
  • ASMB 2010
  • Fundamental
  • Price
  • KOPN $1.66
  • ASMB $13.02
  • Analyst Decision
  • KOPN Strong Buy
  • ASMB Buy
  • Analyst Count
  • KOPN 4
  • ASMB 2
  • Target Price
  • KOPN $2.63
  • ASMB $35.00
  • AVG Volume (30 Days)
  • KOPN 11.0M
  • ASMB 22.1K
  • Earning Date
  • KOPN 03-13-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • KOPN N/A
  • ASMB N/A
  • EPS Growth
  • KOPN N/A
  • ASMB N/A
  • EPS
  • KOPN N/A
  • ASMB N/A
  • Revenue
  • KOPN $44,266,305.00
  • ASMB $28,326,000.00
  • Revenue This Year
  • KOPN $21.20
  • ASMB $282.16
  • Revenue Next Year
  • KOPN $13.55
  • ASMB N/A
  • P/E Ratio
  • KOPN N/A
  • ASMB N/A
  • Revenue Growth
  • KOPN 0.60
  • ASMB N/A
  • 52 Week Low
  • KOPN $0.56
  • ASMB $11.05
  • 52 Week High
  • KOPN $2.79
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • KOPN 51.45
  • ASMB 40.89
  • Support Level
  • KOPN $1.58
  • ASMB $12.10
  • Resistance Level
  • KOPN $1.94
  • ASMB $14.25
  • Average True Range (ATR)
  • KOPN 0.18
  • ASMB 0.60
  • MACD
  • KOPN -0.03
  • ASMB -0.10
  • Stochastic Oscillator
  • KOPN 29.79
  • ASMB 35.11

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: